4-phenylbutyric acid has been researched along with Lung Adenocarcinoma in 1 studies
4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SY | 1 |
| Hong, EH | 1 |
| Jeong, JY | 1 |
| Cho, J | 1 |
| Seo, JH | 1 |
| Ko, HJ | 1 |
| Cho, HJ | 1 |
1 other study available for 4-phenylbutyric acid and Lung Adenocarcinoma
| Article | Year |
|---|---|
Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma.
Topics: A549 Cells; Adenocarcinoma of Lung; Animals; Apoptosis; Esterases; Female; Histone Deacetylase Inhib | 2019 |